Bristol-Myers Squibb Company (BMY) Stock | Share Price | News
BMY · Health Care ·
United States
Bristol-Myers Squibb Company (BMY) is a company in the Health Care sector, based in United States. The stock is held in 23 ETFs we track – with its largest weight of 2.15 % in XUHC (msci-usa-health-care). That means you can hold Bristol-Myers Squibb Company indirectly and diversified through an ETF savings plan.
Very high ETF coverage: 23 of the 95 ETFs we cover hold Bristol-Myers Squibb Company, spread across 11 indices. That puts the stock in more ETFs than 91.5 % of the 4,362 stocks we cover.
Price chart
Performance
| Year to date | +26.4 % | 1 year | +43.1 % |
|---|---|---|---|
| 1 month | +8.0 % | 3 months | +17.5 % |
| Calendar year 2025 | -4.6 % | ||
| Calendar year 2026 | +25.3 % |
Risk metrics
Correlated with
The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.
| Instrument | r | −1 … +1 |
|---|---|---|
| Pfizer Inc. | +0.60 | |
| AbbVie Inc. | +0.57 | |
| Amgen Inc. | +0.57 | |
| Royalty Pharma plc Class A | +0.54 | |
| Gilead Sciences Inc. | +0.49 | |
| Johnson & Johnson | +0.49 | |
| USD/JPY | -0.39 | |
| Seagate Technology Holdings plc | -0.35 | |
| SANTOS | -0.35 |
Key financials
Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY2023 | 45.0 | 8.0 | 17.8 % |
| FY2024 | 48.3 | -8.9 | -18.5 % |
| FY2025 | 48.2 | 7.1 | 14.6 % |
Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.
Held in these ETFs
| ETF | Index | Weight |
|---|---|---|
| XUHC | msci-usa-health-care | 2.15 % |
| XUHL | msci-usa-health-care | 2.15 % |
| SPFS | msci-world-health-care | 1.59 % |
| XDWH | msci-world-health-care | 1.58 % |
| XDEV | msci-world-value | 0.69 % |
| WVAL | msci-world-value | 0.39 % |
| XDEM | msci-world-momentum | 0.37 % |
| XDEQ | msci-world-quality | 0.26 % |
| SXR8 | sp500 | 0.21 % |
| SPYL | sp500 | 0.21 % |
| SPY5 | sp500 | 0.21 % |
| XD9U | msci-usa | 0.21 % |
| XD9D | msci-usa | 0.21 % |
| EUNL | msci-world | 0.15 % |
| XDWD | msci-world | 0.15 % |
| SPPW | msci-world | 0.15 % |
| XDWL | msci-world | 0.15 % |
| SWWD | msci-world | 0.15 % |
| SPYI | msci-acwi-imi | 0.14 % |
| SPSA | msci-acwi-imi | 0.14 % |
| IUSQ | msci-acwi | 0.13 % |
| SPYY | msci-acwi | 0.13 % |
| WIMI | msci-world-imi | 0.13 % |
Want to know how much Bristol-Myers Squibb Company overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.
Stocks with similar ETF exposure
Names that reach a portfolio through largely the same funds as Bristol-Myers Squibb Company — the figure counts the ETFs holding both.
Biogen Inc.BIIB · 22 shared ETFs
CVS Health CorporationCVS · 21 shared ETFs
Pfizer Inc.PFE · 21 shared ETFs · r +0.60- Centene CorporationCNC · 21 shared ETFs
- Cooper Companies Inc.COO · 21 shared ETFs
Zimmer Biomet Holdings Inc.ZBH · 21 shared ETFs
ResMed Inc.RMD · 20 shared ETFs
Medtronic plcMDT · 20 shared ETFs
In the Alysly network
How Bristol-Myers Squibb Company connects to ETFs, indices and neighbouring names — every link is a measured relation, not a recommendation.
- United States Country · domicile
- XUHL ETF · holds
- XUHC ETF · holds
- XDWH ETF · holds
- SPFS ETF · holds
- Health Care Sector · sector
- Biogen Stock · similar ETF exposure
Latest Investment Intelligence News: Stocks
· MixedPOL tumbles 9.4% – August 26, 2026
· MixedSTX climbs 12.6% – August 25, 2026
· Risk-offSelling pressure hits markets, with only 30% of assets higher – August 24, 2026
· MixedCrypto, commodities & FX this week: Sui -9.0% · August 17–21, 2026
· MixedThe week in markets: MSCI Emerging Markets sets the tone for the week (+1.6%) · August 17–21, 2026